The Nightview Etf Performance

NITE Etf  USD 31.94  0.07  0.22%   
The etf secures a Beta (Market Risk) of 1.2, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nightview ETF will likely underperform.

Risk-Adjusted Performance

Strong

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in The Nightview ETF are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Nightview ETF exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Acquisition by Howard John B of 17500 shares of Nightview ETF at 9.81 subject to Rule 16b-3
05/28/2025
2
ETFs to Ride on Teslas Renewed Growth Story - Nasdaq
05/30/2025

Nightview ETF Relative Risk vs. Return Landscape

If you would invest  2,361  in The Nightview ETF on April 21, 2025 and sell it today you would earn a total of  833.00  from holding The Nightview ETF or generate 35.28% return on investment over 90 days. The Nightview ETF is currently generating 0.4914% in daily expected returns and assumes 1.4747% risk (volatility on return distribution) over the 90 days horizon. In different words, 13% of etfs are less volatile than Nightview, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Nightview ETF is expected to generate 1.77 times more return on investment than the market. However, the company is 1.77 times more volatile than its market benchmark. It trades about 0.33 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.29 per unit of risk.

Nightview ETF Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Nightview ETF's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as The Nightview ETF, and traders can use it to determine the average amount a Nightview ETF's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.3332

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsNITE
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.47
  actual daily
13
87% of assets are more volatile

Expected Return

 0.49
  actual daily
9
91% of assets have higher returns

Risk-Adjusted Return

 0.33
  actual daily
26
74% of assets perform better
Based on monthly moving average Nightview ETF is performing at about 26% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nightview ETF by adding it to a well-diversified portfolio.

Nightview ETF Fundamentals Growth

Nightview Etf prices reflect investors' perceptions of the future prospects and financial health of Nightview ETF, and Nightview ETF fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nightview Etf performance.

About Nightview ETF Performance

By analyzing Nightview ETF's fundamental ratios, stakeholders can gain valuable insights into Nightview ETF's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nightview ETF has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nightview ETF has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Nightstar Therapeutics plc, a clinical-stage gene therapy company, focuses on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases in the United Kingdom. The company was incorporated in 2017 and is headquartered in London, the United Kingdom. Nightstar Therapeutics operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 47 people.
Net Loss for the year was (38.9 M).
The Nightview ETF currently holds about 153.46 M in cash with (48.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.58.
Roughly 43.0% of the company outstanding shares are owned by corporate insiders
When determining whether Nightview ETF is a strong investment it is important to analyze Nightview ETF's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nightview ETF's future performance. For an informed investment choice regarding Nightview Etf, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in The Nightview ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
The market value of Nightview ETF is measured differently than its book value, which is the value of Nightview that is recorded on the company's balance sheet. Investors also form their own opinion of Nightview ETF's value that differs from its market value or its book value, called intrinsic value, which is Nightview ETF's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nightview ETF's market value can be influenced by many factors that don't directly affect Nightview ETF's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nightview ETF's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nightview ETF is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nightview ETF's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.